Hillstream BioPharma prices upsized 3.75M-share IPO below range at $4

seekingalpha2022-01-12

Hillstream BioPharma (HILS) has priced its IPO of 3.75M common shares at $4.00/share for aggregate gross proceeds of $15M.The company initially filed to offer3M shares at a price range of $5-$6.Nasdaq...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

gachaboi123
2022-01-12
gachaboi123
Hii
Adren
2022-01-12
Adren
Ok
Huntsilencer
2022-01-12
Huntsilencer
Up
EmmanuelQeen
2022-01-12
EmmanuelQeen
Pls like
0ink
2022-01-12
0ink
Ok
hitithard
2022-01-12
hitithard
K

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142049962?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-12 16:39","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1142049962","market":"us","top_or_hot":-1,"title":"Hillstream BioPharma prices upsized 3.75M-share IPO below range at $4","media":"seekingalpha","content":"<div>\n<p>Hillstream BioPharma (HILS) has priced its IPO of 3.75M common shares at $4.00/share for aggregate gross proceeds of $15M.The company initially filed to offer3M shares at a price range of $5-$6.Nasdaq...</p>\n\n<a href=\"https://seekingalpha.com/news/3787337-hillstream-biopharma-prices-upsized-375m-share-ipo-below-range-at-4\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hillstream BioPharma prices upsized 3.75M-share IPO below range at $4</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHillstream BioPharma prices upsized 3.75M-share IPO below range at $4\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-12 16:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3787337-hillstream-biopharma-prices-upsized-375m-share-ipo-below-range-at-4><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hillstream BioPharma (HILS) has priced its IPO of 3.75M common shares at $4.00/share for aggregate gross proceeds of $15M.The company initially filed to offer3M shares at a price range of $5-$6.Nasdaq...</p>\n\n<a href=\"https://seekingalpha.com/news/3787337-hillstream-biopharma-prices-upsized-375m-share-ipo-below-range-at-4\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/3787337-hillstream-biopharma-prices-upsized-375m-share-ipo-below-range-at-4","article_id":"1142049962","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142049962","pubTimestamp":1641976754,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Hillstream BioPharma (HILS) has priced its IPO of 3.75M common shares at $4.00/share for aggregate g","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Hillstream BioPharma股价上调375万股，低于4美元区间","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HILS":0.9},"content_text":"Hillstream BioPharma (HILS) has priced its IPO of 3.75M common shares at $4.00/share for aggregate gross proceeds of $15M.The company initially filed to offer3M shares at a price range of $5-$6.Nasdaq trading is expected to commence on January 12, 2022.Underwriters' over-allotment is an additional 562.5K shares.Closing date is January 14.Net proceeds will be used for the advancement of Company's product candidates, for general corporate and working capital purposes.Hillstream BioPharma is a biotechnology company developing novel therapeutic candidates for drug resistant and devastating cancers.HILS' most advanced candidate is HSB-1216, an iron mediated cell death modulator, targeting a variety of solid tumors. Below is an overview of company's clinical pipeline.Hillstream intends to submit an investigational new drug application to the FDA for HSB-1216 in 2022, for HSB-888 and HSB-510 in 2023 and for HSB-114 in 2024.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9002878061,"gmtCreate":1641979888635,"gmtModify":1676533668425,"author":{"id":"4087304258366280","authorId":"4087304258366280","name":"gachaboi123","avatar":"https://static.tigerbbs.com/cb83c17f0db9b4c88e80fb28cca1aab8","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"4087304258366280","authorIdStr":"4087304258366280"},"htmlText":"Hii","listText":"Hii","text":"Hii","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002878061","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002847202,"gmtCreate":1641978842530,"gmtModify":1676533668310,"author":{"id":"3585523380475263","authorId":"3585523380475263","name":"Adren","avatar":"https://static.tigerbbs.com/0aadde2926bded6d94841939400c4029","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585523380475263","authorIdStr":"3585523380475263"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002847202","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002845516,"gmtCreate":1641978311435,"gmtModify":1676533668248,"author":{"id":"3583029437333652","authorId":"3583029437333652","name":"Huntsilencer","avatar":"https://static.tigerbbs.com/9b69d6b5db7ba7ec92be9ac8c5c5705c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583029437333652","authorIdStr":"3583029437333652"},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002845516","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002845981,"gmtCreate":1641978051091,"gmtModify":1676533668231,"author":{"id":"3569477879515338","authorId":"3569477879515338","name":"EmmanuelQeen","avatar":"https://static.tigerbbs.com/229c717db2c50af149c3454594cc38dd","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3569477879515338","authorIdStr":"3569477879515338"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002845981","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002842086,"gmtCreate":1641977450257,"gmtModify":1676533668204,"author":{"id":"3582069515093971","authorId":"3582069515093971","name":"0ink","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582069515093971","authorIdStr":"3582069515093971"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002842086","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002846321,"gmtCreate":1641976968681,"gmtModify":1676533668187,"author":{"id":"3570063321997588","authorId":"3570063321997588","name":"hitithard","avatar":"https://static.tigerbbs.com/309ce7b357018aa7b946332c2fe8725c","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3570063321997588","authorIdStr":"3570063321997588"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002846321","repostId":1142049962,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":34,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142049962"}